Applied Health Signals company Livongo Health, today announced the launch of the Study to Understand Gaining Access to Blood Glucose Records (SUGAR), or SUGAR study, a randomized controlled trial in collaboration with the University of California, San Francisco (UCSF). The aim of the clinical trial is to measure the impact of the Livongo for Diabetes program compared to the average standard of care approach to diabetes management utilizing a traditional Bluetooth glucose meter. SUGAR Study
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
WellSpan Health, Sweetch Partner to Deploy AI-Driven App for Diabetes Prevention
WellSpan Health partners with Sweetch to deploy its AI-based app to deliver large-scale prediction and prevention of diabetes to augment its employee wellness program.Diabetes is an epidemic, and our health systems are paying the price. With one in 11 adults affected globally and costs for people suffering from diabetes over 2x higher than those without the disease, it’s a pressing issue – and the latest technologies can help alleviate it.Today, integrated healthcare system WellSpan Health
Read More
Roche Integrates Insulin Data from Novo Nordisk with Diabetes Management Solutions
Roche has signed a development and collaboration agreement with Novo Nordisk, a leader in innovating the therapy of diabetes and obesity. Under the terms of the development and collaboration agreement, the partners will integrate insulin data from Novo Nordisk's connected pen to Roche's open ecosystem, synchronizing with its suite of digital diabetes management solutions including mySugr.People with diabetes spend an average of one hour per day on self-care and have to make up to 50 therapy
Read More
10 Major Trends Shaping The Global Digital Diabetes Market
In the last two years, the digital diabetes care market has seen a substantial progress. In the new report, Digital Diabetes Care Market 2018-2022: Ready to Take Off, Research2Guidance demonstrates how the improvement of digital diabetes solutions has resulted in the increasing demand for them among patients and healthcare organizations. According to the report, the digital diabetes care market has reached a tipping point, which will result in the sustainable growth in the
Read More
Novo Nordisk Launches the Innovation Challenge Focused on Diabetes Management
Novo Nordisk, a global leader in the diabetes space, is seizing the opportunity to advance care and leverage digital health technology through the Novo Nordisk Innovation Challenge. With support from MATTER, a prominent incubator and innovation hub, Novo Nordisk is challenging start-ups, researchers, entrepreneurs, and students to explore, design; and co-develop digital health solutions for the more than 400 million people living with diabetes worldwide.The first phase of the challenge is
Read More
Livongo Health and Abbott Partner to Offer Continuous Glucose Monitoring Insights
Livongo Health, a consumer digital health company empowering people with chronic conditions to live better and healthier lives, today announced that it will be the first comprehensive offering for people with diabetes to integrate continuous glucose data from Abbott’s FreeStyle® Libre Pro System, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals.Through this integration collaboration, Livongo will offer, where appropriate and prescribed, the FreeStyle Libre
Read More
iGlucose Integrates with Validic’s Data Connectivity Platform to Simplify Diabetes Management
Smart Meter, LLC, makers of the iGlucose® Cellular Diabetes Care Solution, announced its integration with Validic, a healthcare data connectivity platform. The integration brings a simple, convenient and affordable diabetes management solution to people with diabetes, healthcare teams, and population management programs. The iGlucose solution, which uses cell-enabled technology to automatically transmit real-time blood glucose results, removes complex technology issues by automatically
Read More
Rimidi Raises $6.575M for Cloud-based Enterprise Solution for Diabetes Management
Rimidi, Inc.(formerly known as Rimidi Diabetes), an Atlanta-based digital health startup that provides software and clinical analytics for chronic disease management, announced it has raised $6.575 million in Series A-1 financing, which includes a strategic investment by Eli Lilly and Company, an investment from Turner Investments, and participation from existing investors Cox Enterprises, Village Capital, The Jump Fund, and JAMB Global. The company plans to use the funding round to fuel growth
Read More
Duke Health to Integrate Glytecc’s Insulin Management with Epic EMR
Duke University Health System has selected Glytec’s eGlycemic Management System to elevate the quality and safety of care for patients with diabetes and others who require insulin therapy. With national statistics indicating that one of every three hospitalized patients requires insulin therapy during their stay, administering the right dose at the right time in accordance with best practices is integral to safe, effective care and speedy recovery. By implementing Glytec’s FDA-cleared eGlycemic
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
